ACAD ACADIA Pharmaceuticals Inc. - Common Stock
$30,66
Harga · Agu 19, 2026
Fundamental per Agu 5, 2026
Rentang 52M
$20–$31
98% of range
Peringkat Analis
BUY
27 analysts
Target Harga
$34
+10% upside
P/E (TTM)
13.3
ROE
38.1%
Margin Laba Bersih
36.5%
Tentang ACADIA Pharmaceuticals Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Baca selengkapnya
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
ACAD Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$30.66
Kapitalisasi Pasar
$5.22B
P/E (TTM)
13.3
EPS (TTM)
$2.30
Pendapatan (TTM)
$1.07B
Imbal Hasil Dividen
—
ROE
38.1%
D/E Utang/Ekuitas
—
Rentang 52M
$20 – $31
ACAD Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$1.07B
2016-12-31
→
2025-12-31
EPS
$2.30
2020-12-31
→
2025-12-31
Arus Kas Bebas
$105M
2016-12-31
→
2025-12-31
Margin
36.5%
2016-12-31
→
2023-12-31
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
ACAD
Median Rekan
P/E (TTM)
13.3
13.2
P/S (TTM)
4.9
55.3
P/B
4.3
3.5
Price / FCF (Harga / FCF)
49.7
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
ACAD
Median Rekan
Operating Margin (Margin Operasi)
9.8%
—
Net Profit Margin (Margin Laba Bersih)
36.5%
-151.2%
ROA
28.4%
-42.2%
ROE
38.1%
-52.8%
ROIC
24.0%
—
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
ACAD
Median Rekan
Current Ratio (Rasio Lancar)
3.8
10.3
Quick Ratio (Rasio Cepat)
1.1
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
ACAD
Median Rekan
Revenue YoY (Pendapatan YoY)
11.9%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
27.5%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
19.4%
—
EPS YoY
69.1%
—
Net Income YoY (Laba Bersih YoY)
72.7%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
ACAD
Median Rekan
ACAD Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
27 analis
- Beli Kuat 7 25,9%
- Beli 14 51,9%
- Tahan 5 18,5%
- Jual 1 3,7%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
20 analis · 2026-08-18
Median
$36.00
Sekarang
$30.66
Rendah
$17.00
Tinggi
$49.00
Target median
$36.00
+17,4%
Target rata-rata
$33.85
+10,4%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.30%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $0.18 | $0.06 | 0.12% |
| 31 Maret 2026 | $0.02 | $0.06 | -0.04% |
| 31 Des. 2025 | $1.60 | $0.14 | 1.5% |
| 30 Sep. 2025 | $0.42 | $0.15 | 0.27% |
| 30 Juni 2025 | $0.16 | $0.14 | 0.02% |
| 31 Maret 2025 | $0.11 | $0.11 | -0.00% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
| DYN | $3.23B | -5.6 | — | — | -57.8% | — |
| PBLS | — | — | — | — | — | — |
| CELC | $4.81B | -26.3 | — | — | -244.3% | — |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 16
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
Neraca 25
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
Arus Kas 13
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
Profitabilitas 8
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
Likuiditas & Solvabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
Tingkat Pertumbuhan 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
Valuasi (TTM) 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
Laporan Laba Rugi 16
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | -335,115,000 | 168,836,000 | 167,827,000 | 166,808,000 | -330,606,000 | 165,974,000 | 165,551,000 | 164,798,000 | -326,136,000 | 164,234,000 | 163,458,000 | 162,263,000 | 128,494 | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | -337,080,000 | 170,650,000 | 168,681,000 | 167,668,000 | -332,613,000 | 166,178,000 | 166,174,000 | 166,623,000 | -327,724,000 | 164,234,000 | 165,046,000 | 162,263,000 | 128,494 | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
Arus Kas 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Profitabilitas 7
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
Valuasi (TTM) 10
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.12B | $1.06B | · | $1.04B | $1.00B | $943M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $134M | $121M | · | $150M | $112M | $102M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 32.4 | 31.4 | · | 24.0 | 32.2 | 27.2 | · | 19.7 | 90.3 | -1849.0 | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.9 | 3.6 | · | 3.5 | 3.6 | 2.9 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| P / FCF | · | 132.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.2% | · | 4.2% | 3.1% | 3.7% | · | 5.1% | 1.1% | -0.05% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $1.07B | $958M | $726M | $517M | $484M |
| Margin Kotor % | — | — | 94.3% | 98.0% | 97.8% |
| Margin Operasi % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| Laba Bersih | $391M | $226M | $-61M | $-216M | $-168M |
| EPS Dilusian | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rasio Lancar | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| Rasio Cepat | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $105M | $157M | $17M | $-114M | $-127M |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 387 pengaju · $3.2B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 56 (+10 vs Kuartal sebelumnya) | 37 (+10 vs Kuartal sebelumnya) | 136 (+11 vs Kuartal sebelumnya) | 100 (-13 vs Kuartal sebelumnya) | +17.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1.085.696.471 | 42.912.904 | 33,44% | Saham |
| STATE STREET CORP | $229.628.164 | 9.076.212 | 7,07% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223.612.785 | 8.838.450 | 6,89% | Saham |
| RTW INVESTMENTS, LP | $180.756.457 | 7.144.524 | 5,57% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $145.822.875 | 5.763.750 | 4,49% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $88.971.384 | 3.516.656 | 2,74% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $73.088.127 | 2.888.204 | 2,25% | Saham |
| Qube Research & Technologies Ltd | $61.899.233 | 2.446.610 | 1,91% | Saham |
| Point72 Asset Management, L.P. | $61.559.150 | 2.433.168 | 1,90% | Saham |
| CITADEL ADVISORS LLC | $53.414.195 | 2.111.233 | 1,65% | Saham |
| Pictet Asset Management Holding SA | $50.146.450 | 1.983.198 | 1,54% | Saham |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49.826.959 | 1.969.445 | 1,53% | Saham |
| MARSHALL WACE, LLP | $44.649.289 | 1.764.794 | 1,38% | Saham |
| BRAIDWELL LP | $41.653.895 | 1.646.399 | 1,28% | Saham |
| NORGES BANK | $41.069.692 | 1.623.308 | 1,26% | Saham |
| Frazier Life Sciences Management, L.P. | $36.386.409 | 1.438.198 | 1,12% | Saham |
| Artisan Partners Limited Partnership | $33.525.890 | 1.325.134 | 1,03% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $32.449.679 | 1.282.596 | 1,00% | Saham |
| GOLDMAN SACHS GROUP INC | $32.070.584 | 1.267.612 | 0,99% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30.520.301 | 1.206.336 | 0,94% | Saham |
| D. E. Shaw & Co., Inc. | $28.330.257 | 1.119.773 | 0,87% | Saham |
| Allspring Global Investments Holdings, LLC | $26.143.513 | 1.037.441 | 0,81% | Saham |
| TWO SIGMA INVESTMENTS, LP | $23.452.898 | 926.992 | 0,72% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $23.082.961 | 912.370 | 0,71% | Saham |
| BANK OF AMERICA CORP /DE/ | $21.702.062 | 857.789 | 0,67% | Saham |
| PANAGORA ASSET MANAGEMENT INC | $17.985.922 | 710.906 | 0,55% | Saham |
| Fisher Asset Management, LLC | $17.690.535 | 699.230 | 0,54% | Saham |
| Allianz Asset Management GmbH | $15.730.341 | 706.664 | 0,48% | Saham |
| RICE HALL JAMES & ASSOCIATES, LLC | $15.657.841 | 618.887 | 0,48% | Saham |
| MILLENNIUM MANAGEMENT LLC | $14.925.077 | 589.924 | 0,46% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14.771.456 | 583.852 | 0,45% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.903.000 | 510.000 | 0,40% | Saham |
| Hudson Bay Capital Management LP | $11.764.500 | 465.000 | 0,36% | Saham |
| GLENMEDE TRUST CO NA | $11.656.544 | 460.733 | 0,36% | Saham |
| JUPITER ASSET MANAGEMENT LTD | $11.599.190 | 458.466 | 0,36% | Saham |
| Public Sector Pension Investment Board | $11.014.988 | 435.375 | 0,34% | Saham |
| MACKENZIE FINANCIAL CORP | $10.646.872 | 420.825 | 0,33% | Saham |
| Ishara Investments LP | $10.373.000 | 410.000 | 0,32% | Saham |
| TWO SIGMA ADVISERS, LP | $9.888.042 | 370.200 | 0,30% | Saham |
| Balyasny Asset Management L.P. | $9.817.007 | 388.024 | 0,30% | Saham |
| BlackRock, Inc. | $9.281.482 | 366.857 | 0,29% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $9.020.310 | 356.534 | 0,28% | Saham |
| AMERIPRISE FINANCIAL INC | $8.039.177 | 317.754 | 0,25% | Saham |
| PRUDENTIAL FINANCIAL INC | $7.985.313 | 315.625 | 0,25% | Saham |
| Alyeska Investment Group, L.P. | $7.850.261 | 310.287 | 0,24% | Saham |
| RHUMBLINE ADVISERS | $7.663.389 | 302.902 | 0,24% | Saham |
| Schonfeld Strategic Advisors LLC | $7.189.171 | 284.157 | 0,22% | Saham |
| Edgestream Partners, L.P. | $7.167.515 | 283.301 | 0,22% | Saham |
| Logos Global Management LP | $6.325.000 | 250.000 | 0,19% | Saham |
| LAZARD ASSET MANAGEMENT LLC | $6.263.496 | 247.569 | 0,19% | Saham |
| FMR LLC | $6.052.317 | 239.222 | 0,19% | Saham |
| Swiss National Bank | $5.841.871 | 230.904 | 0,18% | Saham |
| VICTORY CAPITAL MANAGEMENT INC | $5.432.213 | 214.712 | 0,17% | Saham |
| ALPS ADVISORS INC | $4.985.340 | 197.049 | 0,15% | Saham |
| ENVESTNET ASSET MANAGEMENT INC | $4.926.239 | 194.713 | 0,15% | Saham |
| Legal & General Group Plc | $4.918.245 | 194.397 | 0,15% | Saham |
| FIRST TRUST ADVISORS LP | $4.664.965 | 184.386 | 0,14% | Saham |
| NEW YORK STATE COMMON RETIREMENT FUND | $4.364.807 | 172.522 | 0,13% | Saham |
| Birchview Capital, LP | $4.326.300 | 171.000 | 0,13% | Saham |
| MARTINGALE ASSET MANAGEMENT L P | $4.247.693 | 167.893 | 0,13% | Saham |
| Tetragon Partners GP Ltd | $4.247.238 | 167.875 | 0,13% | Saham |
| GREAT LAKES ADVISORS, LLC | $3.822.526 | 151.088 | 0,12% | Saham |
| AMERICAN CENTURY COMPANIES INC | $3.635.306 | 143.688 | 0,11% | Saham |
| STEMPOINT CAPITAL LP | $3.622.125 | 143.167 | 0,11% | Saham |
| ALLIANCEBERNSTEIN L.P. | $3.585.329 | 161.066 | 0,11% | Saham |
| Squarepoint Ops LLC | $3.542.329 | 140.013 | 0,11% | Saham |
| ORBIMED ADVISORS LLC | $3.466.100 | 137.000 | 0,11% | Saham |
| Erste Asset Management GmbH | $3.369.240 | 133.700 | 0,10% | Saham |
| Emerald Investment Advisers, LLC | $3.333.326 | 131.752 | 0,10% | Saham |
| Caption Management, LLC | $3.289.000 | 130.000 | 0,10% | Opsi jual |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.130.217 | 123.724 | 0,10% | Saham |
| WELLS FARGO & COMPANY/MN | $3.084.475 | 121.916 | 0,09% | Saham |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.077.311 | 138.244 | 0,09% | Saham |
| Longaeva Partners L.P. | $2.968.145 | 117.318 | 0,09% | Saham |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.948.791 | 116.553 | 0,09% | Saham |
| Trexquant Investment LP | $2.935.357 | 116.022 | 0,09% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2.909.778 | 115.011 | 0,09% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $2.868.477 | 113.289 | 0,09% | Saham |
| Rafferty Asset Management, LLC | $2.789.426 | 110.254 | 0,09% | Saham |
| Nan Fung Group Holdings Ltd | $2.605.495 | 102.984 | 0,08% | Saham |
| RAYMOND JAMES FINANCIAL INC | $2.406.232 | 95.108 | 0,07% | Saham |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.344.000 | 92.648 | 0,07% | Saham |
| ROYCE & ASSOCIATES LP | $2.324.691 | 91.885 | 0,07% | Saham |
| HOHIMER WEALTH MANAGEMENT, LLC | $2.322.540 | 91.800 | 0,07% | Saham |
| Point72 Europe (London) LLP | $2.305.047 | 108.015 | 0,07% | Saham |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2.134.076 | 79.898 | 0,07% | Saham |
| Campbell & CO Investment Adviser LLC | $2.108.527 | 83.341 | 0,06% | Saham |
| Verdad Advisers, LP | $2.090.514 | 82.629 | 0,06% | Saham |
| VOYA INVESTMENT MANAGEMENT LLC | $2.072.576 | 81.920 | 0,06% | Saham |
| CITADEL ADVISORS LLC | $2.049.300 | 81.000 | 0,06% | Opsi beli |
| GUGGENHEIM CAPITAL LLC | $1.979.776 | 78.252 | 0,06% | Saham |
| WESBANCO BANK INC | $1.978.460 | 78.200 | 0,06% | Saham |
| Phocas Financial Corp. | $1.954.299 | 77.245 | 0,06% | Saham |
| MetLife Investment Management, LLC | $1.899.043 | 75.061 | 0,06% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.850.493 | 73.142 | 0,06% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.788.331 | 70.685 | 0,06% | Saham |
| Freestone Grove Partners LP | $1.755.643 | 69.393 | 0,05% | Saham |
| CenterBook Partners LP | $1.743.878 | 68.928 | 0,05% | Saham |
| CANADA PENSION PLAN INVESTMENT BOARD | $1.722.930 | 68.100 | 0,05% | Saham |
| Illinois Municipal Retirement Fund | $1.693.380 | 66.932 | 0,05% | Saham |
Orang dalam perusahaan 37 orang dalam · 19 pejabat · 19 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Stephen Davis | CEO | 6 Jan. 2024 M | 96.521 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 25 Maret 2011 A | 69.916 | 0 | 0 | $0 |
| Elena Ridloff | EVP and CFO | 29 April 2021 M | 10.553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 15 Okt. 2018 A | — | 0 | 0 | $0 |
| Thomas H Aasen | Exec. VP, CFO & CBO | 25 Maret 2011 A | 13.899 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 21 Nov. 2022 M | 61.234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 16 Juni 2006 S | 317.756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, Head of Commercial | 6 Jan. 2024 M | 30.949 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 29 Juli 2026 M | 18.994 | 0 | 2 | $-432.662 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 26 Juni 2026 S | 13.088 | 0 | 2 | $-412.253 |
| Austin D. Kim | EVP,General Counsel, Secretary | 6 Jan. 2024 M | 46.901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 10 Feb. 2023 A | — | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 6 Jan. 2021 M | 8.059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 15 Okt. 2019 M | 270 | 0 | 0 | $0 |
| Glenn Baity | VP, GC & Sec. | 25 Maret 2011 A | — | 0 | 0 | $0 |
| Roger Mills | Executive VP, Development | 25 Maret 2011 A | — | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 8 Juli 2009 M | 20.000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 7 Maret 2008 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 11 Maret 2005 A | — | 0 | 0 | $0 |
| Adora Ndu | Direktur | 29 Mei 2026 A | 32.908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | Direktur | 29 Mei 2026 A | 33.489 | 0 | 0 | $0 |
| Jonathan Poole | Direktur | 29 Mei 2026 A | 2.010 | 0 | 0 | $0 |
| James M Daly | Direktur | 29 Mei 2026 A | 12.148 | 0 | 0 | $0 |
| Laura Brege | Direktur | 29 Mei 2026 A | 23.202 | 0 | 0 | $0 |
| Edmund Harrigan | Direktur | 29 Mei 2026 A | 43.148 | 0 | 0 | $0 |
| Daniel B Soland | Direktur | 1 Juni 2023 A | 28.002 | 0 | 0 | $0 |
| Torsten Rasmussen | Direktur | 11 Juni 2010 A | 4.000 | 0 | 0 | $0 |
| Leslie L Iversen | Direktur | 11 Juni 2010 A | 9.000 | 0 | 0 | $0 |
| Mary Ann Gray | Direktur | 11 Juni 2010 A | — | 0 | 0 | $0 |
| Michael T Borer | Direktur | 11 Juni 2010 A | — | 0 | 0 | $0 |
| Lester J Ph D Kaplan | Direktur | 11 Juni 2010 A | 4.000 | 0 | 0 | $0 |
| Gordon M Binder | Direktur | 12 Juni 2009 A | 14.364 | 0 | 0 | $0 |
| Alan G Walton | Direktur | 12 Juni 2009 A | 25.979 | 0 | 0 | $0 |
| Martien Van Osch | Direktur | 10 Juni 2005 A | 1.168.892 | 0 | 0 | $0 |
| GORDON CARL L | Direktur | 20 April 2005 A | 774.006 | 0 | 0 | $0 |
| Mark C. Schneyer | — | 6 Agu 2026 M | 67.828 | 0 | 3 | $-587.248 |
| John Joseph Kaiser | — | 20 Okt. 2008 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 6 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 pengajuan | 26 Feb. 2026 | 25,40% | Amandemen | — | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 pengajuan | 6 Juni 2013 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 2 Mei 2005 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 2 Mei 2005 | — | Pengajuan awal | — | SEC |
| Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan, Orang pelapor yang tidak diungkapkan | 2 Mei 2005 | — | Pengajuan awal | — | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 29 April 2005 | — | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 77 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IBRN · iShares Trust | 4,89% | 13.265 SH | 8 Agu 2026 | Harian |
| PBE · Invesco Exchange-Traded Fund Trust | 3,29% | 407.914 SH | 8 Agu 2026 | Harian |
| SBIO · ALPS ETF Trust | 2,35% | 175.740 NS | 31 Mei 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,87% | 109.972 SH | 8 Agu 2026 | Harian |
| BBP · ETFis Series Trust I | 1,32% | 34.855 NS | 30 April 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 1,25% | 59.514 SH | 8 Agu 2026 | Harian |
| LABU · Direxion Shares ETF Trust | 0,85% | 195.542 NS | 30 April 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,56% | 13.607 NS | 30 April 2026 | N-PORT |
| IJT · iShares Trust | 0,40% | 1.176.933 SH | 8 Agu 2026 | Harian |
| OASC · Unified Series Trust | 0,39% | 15.269 NS | 31 Mei 2026 | N-PORT |
| IBB · iShares Trust | 0,37% | 1.239.145 SH | 8 Agu 2026 | Harian |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,35% | 150.827 SH | 8 Agu 2026 | Harian |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,34% | 9.317 SH | 8 Agu 2026 | Harian |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,27% | 61.606 NS | 30 April 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,24% | 24.003 NS | 31 Mei 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,23% | 20.369 SH | 8 Agu 2026 | Harian |
| IWO · iShares Trust | 0,23% | 1.166.817 SH | 8 Agu 2026 | Harian |
| XJR · iShares Trust | 0,23% | 14.974 SH | 8 Agu 2026 | Harian |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 89.945 NS | 31 Mei 2026 | N-PORT |
| IJR · iShares Trust | 0,20% | 7.728.433 SH | 8 Agu 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 137.860 SH | 8 Agu 2026 | Harian |
| BIB · ProShares Trust | 0,19% | 6.303 NS | 31 Mei 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,17% | 443.221 SH | 8 Agu 2026 | Harian |
| BKSE · BNY Mellon ETF Trust | 0,17% | 6.035 NS | 30 April 2026 | N-PORT |
| SMMV · iShares Trust | 0,17% | 17.063 SH | 8 Agu 2026 | Harian |
| SMLF · iShares Trust | 0,15% | 219.745 SH | 8 Agu 2026 | Harian |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 47.683 NS | 30 April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,14% | 137.072 SH | 8 Agu 2026 | Harian |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 81.552 NS | 30 April 2026 | N-PORT |
| SAA · ProShares Trust | 0,12% | 1.498 NS | 31 Mei 2026 | N-PORT |
| IWM · iShares Trust | 0,12% | 3.281.125 SH | 8 Agu 2026 | Harian |
| ISCG · iShares Trust | 0,11% | 39.884 SH | 8 Agu 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 741.237 SH | 8 Agu 2026 | Harian |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,09% | 66.331 SH | 8 Agu 2026 | Harian |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.699.377 SH | 8 Agu 2026 | Harian |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,09% | 115.210 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,08% | 526.641 NS | 30 April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 16.957 NS | 30 April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,07% | 5.921 NS | 31 Mei 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 599.784 NS | 31 Mei 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 5.636 SH | 8 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 54.956 NS | 30 April 2026 | N-PORT |
| IEUS · iShares Trust | 0,04% | 7.411 SH | 8 Agu 2026 | Harian |
| SMDX · Tidal Trust III | 0,04% | 2.306 NS | 30 April 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 4.033 SH | 8 Agu 2026 | Harian |
| UWM · ProShares Trust | 0,04% | 4.631 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.457.036 SH | 8 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2.944.095 SH | 8 Agu 2026 | Harian |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,04% | 14.209 SH | 8 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,04% | 346.329 SH | 8 Agu 2026 | Harian |